Print Page | Close Page

 
 

Soter Bio

Address: Houston, Texas.
 
Country: USA
 
Sectors: Collaborations & Partnerships- R&D, Collaborations & Partnerships-Services, Collaborations & Partnerships-Manufacture, Contract Manufacturing, Contract Research & Development
 
Website: https://soter-bio.com/
 
- - -
 

About Us

Founded in 2025 and headquartered in Houston, Texas, Soter Bio is a U.S.-based Contract Development and Manufacturing Organization (CDMO) dedicated to restoring and strengthening domestic manufacturing of advanced biomolecules and active pharmaceutical ingredients (APIs) under U.S. regulatory oversight. Soter Bio provides end-to-end development and regulated manufacturing infrastructure — from starting materials through finished drug product — supporting both Research Use Only (RUO) and Good Manufacturing Practice (GMP) programs. We are establishing a dedicated, U.S.-based platform for advanced RNA manufacturing, integrating: Closed, automated production systems Scalable domestic infrastructure Secure, compliant manufacturing environments This platform is designed to repatriate critical biomanufacturing capabilities, strengthen supply-chain security, and deliver reliable, scalable capacity aligned with industry needs, public health priorities, and national preparedness objectives.

 
- - -
 

Sectors

  • Collaborations & Partnerships- R&D
  • Collaborations & Partnerships-Services
  • Collaborations & Partnerships-Manufacture
 
  • Contract Manufacturing
  • Contract Research & Development
 
- - -
 

Categories

  • Biologics
  • Drug Discovery Services
  • Gene Therapy
  • Gene Therapy Products
  • Cell Therapy
  • Cell Therapy Products
 
  • Messenger RNA
  • Plasmid DNA
  • RNA based Products
  • Bioprocess Development
  • Lipid Nanoparticles (LNPs)
  • Bioconjugation
 
- - -
 

News

 
04th March 2026
 

Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing

 

The Woodlands, Texas— February 24, 2026/ Cision / – Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with Soter Bio, a CDMO specializing in RNA and RNA–lipid nanoparticle (LNP) manufacturing for research and GMP applications. Together, the companies will support integrated manufacturing pathways for complex cell therapy programs requiring coordinated biomolecule and cellular processing.

 
- - -
 
Printed: 15-Mar-2026 at 12:14:25 hrs
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com